| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 3.75% | 2.18% | -53.65% | 19/68 | 2.31% | 羚锐制药 | 6.99% | 行业排名> |
| 2025-12-31 | 8.09% | 8.3% | 7.58% | 22/68 | 2.77% | 羚锐制药 | 22.39% | 行业排名> |
| 2025-09-30 | 7.52% | -7.05% | 36.73% | 25/68 | 4.88% | 达仁堂 | 25.38% | 行业排名> |
| 2025-06-30 | 5.5% | -1.08% | 49.86% | 21/68 | 3.21% | 羚锐制药 | 13.67% | 行业排名> |
| 2025-03-31 | 3.67% | -3.67% | -50.87% | 16/68 | 2.25% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 7.47% | 24.29% | -7.66% | 25/68 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 8.09% | 14.59% | 45.5% | 20/68 | 5.46% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 5.56% | 6.51% | 45.93% | 21/68 | 2.54% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 3.81% | 7.32% | -36.61% | 16/68 | 1.97% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 6.01% | 102.36% | -14.87% | 40/68 | 2.03% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 7.06% | 95.03% | 35.25% | 36/68 | 7.62% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 5.22% | 66.77% | 47.04% | 28/68 | 5.2% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 3.55% | 47.3% | 19.53% | 26/68 | 3.31% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 2.97% | -39.63% | -17.96% | 50/68 | 6.79% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 3.62% | -29.43% | 15.65% | 44/68 | 5.19% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 3.13% | 0.64% | 29.88% | 42/68 | 3.33% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 2.41% | 4.78% | -51.02% | 32/68 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 4.92% | 117.7% | -4.09% | 46/68 | 4.51% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 5.13% | 56.88% | 64.95% | 46/68 | 7.47% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 3.11% | 79.77% | 35.22% | 48/68 | 4.6% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 2.3% | 55.41% | 1.77% | 36/68 | 2.63% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 2.26% | 665% | -30.89% | 54/68 | 0.07% | 长药退 | 7.37% | 行业排名> |
| 2020-09-30 | 3.27% | -57.86% | 89.02% | 52/68 | 6.89% | 以岭药业 | 7.15% | 行业排名> |
| 2020-06-30 | 1.73% | -66.54% | 16.89% | 50/68 | 3.83% | 沃华医药 | 22.84% | 行业排名> |
| 2020-03-31 | 1.48% | -42.19% | 470% | 43/68 | 2.18% | 沃华医药 | 19.47% | 行业排名> |
| 2019-12-31 | -0.4% | -104.51% | -105.15% | 57/68 | 6.88% | 沃华医药 | 12.7% | 行业排名> |
| 2019-09-30 | 7.76% | 4.72% | 50.1% | 31/68 | 7.39% | 济川药业 | 7.33% | 行业排名> |
| 2019-06-30 | 5.17% | 9.3% | 101.95% | 30/68 | 4.75% | 济川药业 | 27.43% | 行业排名> |
| 2019-03-31 | 2.56% | 20.75% | -71.11% | 36/68 | 2.94% | 济川药业 | 23.05% | 行业排名> |
| 2018-12-31 | 8.86% | 25.32% | 19.57% | 38/68 | 7.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-09-30 | 7.41% | 34.48% | 56.66% | 32/68 | 8.02% | 华润三九 | 10.23% | 行业排名> |
| 2018-06-30 | 4.73% | 20.97% | 123.11% | 33/68 | 5.05% | 济川药业 | 32.79% | 行业排名> |
| 2018-03-31 | 2.12% | 37.66% | -70.01% | 40/68 | 2.78% | 济川药业 | 27.55% | 行业排名> |
| 2017-12-31 | 7.07% | 490.61% | 28.31% | 45/68 | 9.95% | 济川药业 | 17.62% | 行业排名> |
| 2017-09-30 | 5.51% | 114.4% | 40.92% | 45/68 | 8.4% | 济川药业 | 10.07% | 行业排名> |
| 2017-06-30 | 3.91% | 162.42% | 153.9% | 43/68 | 5.23% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-03-31 | 1.54% | -40.08% | 185.08% | 43/68 | 2.66% | 济川药业 | 24.2% | 行业排名> |
| 2016-12-31 | -1.81% | -117.24% | -170.43% | 62/68 | 10.19% | *ST大药 | 15.31% | 行业排名> |
| 2016-09-30 | 2.57% | -76.87% | 72.48% | 50/68 | 9.47% | 济川药业 | 14.64% | 行业排名> |
| 2016-06-30 | 1.49% | -77.49% | -42.02% | 54/68 | 5.15% | 济川药业 | 7.64% | 行业排名> |
| 2016-03-31 | 2.57% | -30.73% | -75.52% | 31/68 | 4.17% | 维康药业 | 38.23% | 行业排名> |

微信公众号
证券之星APP


